Tian Zhang: Kidney cancer pathology, from histology to molecular classification

Tian Zhang shared a post by Samson W. Fine, Attending Pathologist at Memorial Sloan Kettering Cancer Center, on X, adding:

“Thorough discussion with Samson W. Fine at Memorial Sloan Kettering Cancer Center on kidney cancer pathology, from histology to molecular classification at KidneyCAN.”

Quoting Samson W. Fine’s post:

“Excited to travel New York City to Boston to join KidneyCAN for Kidney Cancer Research Summit 2024 (KCRS24) – looking forward to interacting with Medical Twitter colleagues and overviewing ‘Taxonomic Evolution in Kidney Cancer with Emphasis on Molecularly-Defined Renal Cell Carcinoma (RCC)’ in Genitourinary pathology session chaired by Rohit Mehra and Payal Kapur.”

Source: Tian Zhang/X and Samson W. Fine/X

Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma.

She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee. She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.